Downstream Processing Featured Articles

  1. TAP Collaborates With CCRM On Process Optimisation Project For Cell Therapies 12/3/2012

    TAP Biosystems, a leading supplier of innovative cell culture systems and consumables for life science applications, has joined the Centre for Commercialization of Regenerative Medicine’s (CCRM) industry consortium to translate laboratory cell culture conditions into optimized processes and media for commercial production of cellular therapies.

  2. iBio, Inc. And GE Healthcare Form New Global Alliance 7/26/2012

    iBio, Inc., and GE Healthcare, the healthcare business of GE, announced recently a new global alliance to commercialize plant-based technologies for the manufacture of biopharmaceuticals and vaccines.

  3. New' Estrogen Receptor Found To Be Key Player In Tamoxifen Resistance 10/31/2008
    Researchers at Georgetown University Medical Center have discovered a novel way in which breast cancer cells become resistant to tamoxifen, the world's largest-selling breast cancer prevention and treatment drug.
  4. Saint-Gobain Introduces Sani-Tech® Ultra 6/27/2012

    Saint-Gobain Performance Plastics continues its long tradition of innovation in ultra-pure tubing technology with new Sani-Tech® Ultra. This platinum-cured silicone tubing meets the stringent requirements of demanding biopharmaceutical process applications while delivering improved performance in a number of areas.

  5. Roche Receives FDA Clearance For Herpes Simplex Virus Type 1 And 2 Tests 9/4/2012

    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its IgG Antibody to herpes simplex virus (HSV) types 1 and 2 assays for use on cobas® modular platforms. The tests are intended for use with sexually active individuals and expectant mothers as an aid in the presumptive diagnosis of HSV-1 and HSV-2 infection. 

  6. Researchers 'Watch' Antibiotics Attack Tuberculosis Bacteria Inside Cells 11/1/2012

    Weill Cornell Medical College researchers report that mass spectrometry, a tool currently used to detect and measure proteins and lipids, can also now allow biologists to "see" for the first time exactly how drugs work inside living cells to kill infectious microbes.

  7. Is There An Enzyme In Your Future? 8/25/1998
    A method for reducing the chemical steps in vitamin C synthesis from six to two underscores the growing importance of enzymes in organic synthesis...
  8. GeoVax Announces Enrollment Completion For Phase 1/2 Clinical Trial For HIV/AIDS Therapeutic Vaccine 1/10/2013

    GeoVax Labs, Inc. (OTCQB: GOVX), an Atlanta-based biopharmaceutical firm developing vaccines to prevent and treat HIV/AIDS, announced it has completed enrollment in a nine-patient Phase 1/2 clinical trial testing the safety, immunogenicity and ability of its DNA/MVA vaccine to elicit protective immune responses in HIV-infected individuals.

  9. Avanti J-26S High Performance Centrifuge Provides Enhanced Environmental, Safety Benefits 8/8/2012

    The newly redesigned Avanti J-26S high performance centrifuge from Beckman Coulter Life Sciences combines important environmental benefits with increased BioSafety* features.

  10. Researchers Identify Role For Protein Linked To Obesity, Type 2 Diabetes 12/17/2012

    Researchers at UT Southwestern Medical Center have taken another step toward better understanding the metabolic functions of obesity and its connection to type 2 diabetes.